Efficacy of pharmaceutical care in dyslipidemia: systematic review


  • Dauana Pitano Eizerik
  • Waldomiro Carlos Manfroi


Farmacologia Clínica, Dislipidemia


Many patients undergoing treatment with lipid-lowering drugs do not reach their therapeutic goal for a number of reasons: nonadherence, polypharmacy, adverse reactions. Pharmaceutical care aims at increasing therapeutic adherence, decreasing toxicity and improving outcomes, preventing and solving drug-related problems. We performed a systematic review of the literature to evaluate pharmaceutical care efficacy in the management of dyslipidemia. The MEDLINE database (1966 to May 2006) was searched for articles, and the Cochrane Library for clinical trials. Inclusion criteria were studies consisting of randomized clinical trials evaluating pharmaceutical care efficacy in dyslipidemia, with language restriction. MEDLINE search yielded six articles. Search in the Cochrane Library did not add any new clinical trial. All selected articles had positive results of pharmaceutical intervention in dyslipidemia. Cardiovascular diseases, especially dyslipidemia, have characteristics suggesting need of treatment guidance and monitoring. According to reviewed articles, pharmaceutical care contributes to better treatment of dyslipidemia


Download data is not yet available.

Author Biographies

Dauana Pitano Eizerik

Mestranda do Programa de Pós-Graduação da Área da Saúde: Cardiologia e Ciências Cardiovasculares – FAMED / Universidade Federal do Rio Grande do Sul (UFRGS) - Hospital de Clínicas de Porto Alegre (HCPA)

Waldomiro Carlos Manfroi

Professor Doutor do PPG – Cardiologia – FAMED / UFRGS - HCPA



How to Cite

Eizerik DP, Manfroi WC. Efficacy of pharmaceutical care in dyslipidemia: systematic review. Clin Biomed Res [Internet]. 2008Apr.15 [cited 2022May23];28(1). Available from: https://seer.ufrgs.br/index.php/hcpa/article/view/458



Review Articles